The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae.
Open accessAbstract
The accumulation of excessive quantities of sphingomyelin in tissues of patients with Niemann-Pick disease was demonstrated by Klenk in 19341, 2 and has been amply confirmed by other investigators.3-5A study by Crocker and Mays6 in- dicated that the rate of biosynthesis of sphingomyelin in tissues from these patients appeared to be essentially normal.These findings suggested that the metabolic lesion in this condition might be of a catabolic nature.We have recently obtained evidence for the presence of a specific enzyme in liver tissue which catalyzes the hydrolysis of sphingomyelin.7 The enzyme was partially purified from rat liver tissue, and the products of the reaction were demonstrated to be phosphorylcholine and ceramide.The most highly purified enzyme preparations did not catalyze the hydrolysis of lecithin or phosphatidylethanolamine.Lecithin, however, appeared to be a competitive inhibitor of the reaction.Similar enzymatic activity could be detected in human liver tissue.The present report describes experiments in which the level of the sphingomyelin-cleaving enzyme in liver and kidney tissue obtained from six patients with the classic infantile form of Niemann- Pick disease8 is compared with the values found in a liver biopsy sample from a normal human adult and liver and kidney tissue of patients with various other dis- orders.Materials and Methods.-Sphingomyelinlabeled with C14 in the methyl carbon atoms of the choline portion of the molecule was synthesized as described previously.7Samples of liver and kidney tissue were homogenized in 10 vol of 0.25 M sucrose with an all-glass TenBroeck homoge- nizer and centrifuged at 600 X g for 12 min.Suitable aliquots of the supernatant suspensions were
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolism of glucocerebrosides II. Evidence of an enzymatic deficiency in Gaucher's disease
Brady, R. O., Kanfer, J. N., & Shapiro, D. (1965) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(65)90743-6 · Cited by 807
Self-citationRapid Sensitive Method for Determining H3-Water in Body Fluids by Liquid Scintillation Spectrometry.
Werbin, H., Chaikoff, I. L., & Imada, M. R. (1959) · Experimental Biology and Medicine · doi:10.3181/00379727-102-25125 · Cited by 83
Cited by
Vanier, M. T. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-16 · Cited by 1,222
An Overview of Sphingolipid Metabolism: From Synthesis to Breakdown
Gault, C. R., Obeid, L. M., & Hannun, Y. A. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-6741-1_1 · Cited by 1,071
Santana, P., Peña, L. A., Haimovitz-Friedman, A., Martin, S., Green, D., McLoughlin, M., Cordon-Cardo, C., Schuchman, E. H., Fuks, Z., & Kolesnick, R. (1996) · Cell · doi:10.1016/s0092-8674(00)80091-4 · Cited by 797
Vanier, M., & Millat, G. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00147.x · Cited by 578
Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease
Horinouchi, K., Erlich, S., Perl, D. P., Ferlinz, K., Bisgaier, C. L., Sandhoff, K., Desnick, R. J., Stewart, C. L., & Schuchman, E. H. (1995) · Nature Genetics · doi:10.1038/ng0795-288 · Cited by 471
A defect in cholesterol esterification in Niemann-Pick disease (type C) patients.
Pentchev, P. G., Comly, M. E., Kruth, H. S., Vanier, M. T., Wenger, D. A., Patel, S., & Brady, R. O. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.8247 · Cited by 397
Self-citationKornhuber, J., Tripal, P., Reichel, M., Mühle, C., Rhein, C., Muehlbacher, M., Groemer, T. W., & Gulbins, E. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000315101 · Cited by 354
Acid and neutral sphingomyelinases: roles and mechanisms of regulation
Marchesini, N., & Hannun, Y. A. (2004) · Biochemistry and Cell Biology · doi:10.1139/o03-091 · Cited by 339
Types A and B Niemann-Pick disease
Schuchman, E. H., & Desnick, R. J. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.12.008 · Cited by 334
Acidic Sphingomyelinase Mediates Entry of N. gonorrhoeae into Nonphagocytic Cells
Grassmé, H., Gulbins, E., Brenner, B., Ferlinz, K., Sandhoff, K., Harzer, K., Lang, F., & Meyer, T. F. (1997) · Cell · doi:10.1016/s0092-8674(00)80448-1 · Cited by 320
Levade, T., & Jaffrézou, J.-P. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00038-4 · Cited by 299
Consequences of NPC1 and NPC2 loss of function in mammalian neurons
Walkley, S. U., & Suzuki, K. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.08.011 · Cited by 274
Cloned mammalian neutral sphingomyelinase: Functions in sphingolipid signaling?
Tomiuk, S., Hofmann, K., Nix, M., Zumbansen, M., & Stoffel, W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3638 · Cited by 268
Ferreira, C. R., & Gahl, W. A. (2017) · Translational Science of Rare Diseases · doi:10.3233/trd-160005 · Cited by 263
Ceramide function in the brain: when a slight tilt is enough
Mencarelli, C., & Martinez–Martinez, P. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1038-x · Cited by 263
Enzyme Replacement for Lysosomal Diseases
Brady, R. O. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.110104.115650 · Cited by 254
Self-citationSmith, E. L., & Schuchman, E. H. (2008) · The FASEB Journal · doi:10.1096/fj.08-108043 · Cited by 213
Exploring Sphingolipid Implications in Neurodegeneration
Alessenko, A. V., & Albi, E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00437 · Cited by 141
TRPMLs and TPCs: targets for lysosomal storage and neurodegenerative disease therapy?
Krogsaeter, E., Rosato, A. S., & Grimm, C. (2022) · Cell Calcium · doi:10.1016/j.ceca.2022.102553 · Cited by 31
Metadata
- Authors
- Brady, R. O., Kanfer, J. N., Mock, M. B., & Fredrickson, D. S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1966-02
- Volume
- 55
- Issue
- 2
- Pages
- 366-369
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1980723388
- Cited by
- 427
- References
- 2
- FWCI
- 21.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.